NHS National Framework Agreement for the Supply of products for the management of Hereditary Angioedema
National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
Buyer
NHS England
Value
£198,666,666
Published
21 Jul 2022
Closes
16 Mar 2022
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
33141520
Plasma extracts
33141510
Blood products
Lots
Lot Lot 1 Lot 1 – C1 Esterase – Recombinant IV (acute treatment)
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options wil...
Delivery: United Kingdom
Lot Lot 3 Lot 3 - C1 Esterase – Plasma derived IV (prophylaxis treatment)
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options wil...
Delivery: United Kingdom
Lot Lot 6 Lot 6 - Lanadelumab
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options wil...
Delivery: United Kingdom
Lot Lot 7 Lot 7 - Berotralstat
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options wil...
Delivery: United Kingdom
Lot Lot 2 Lot 2 - C1 Esterase – Plasma derived IV (acute treatment)
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options wil...
Delivery: United Kingdom
Lot Lot 4 Lot 4 - C1 Esterase – Plasma derived Subcut (prophylaxis treatment)
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options wil...
Delivery: United Kingdom
Lot Lot 5 Lot 5 - Icatibant
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. The framework will commence on 1 July 2022 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options wil...
Delivery: United Kingdom
Lot 1 Lot 1 – C1 Esterase – Recombinant IV (acute treatment)
Value not provided
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Offer reference number: CM/PHS/19/5583. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreemen...
Delivery: United Kingdom
Lot 3 Lot 3 - C1 Esterase – Plasma derived IV (prophylaxis treatment)
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Offer reference number: CM/PHS/19/5583. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreemen...
Delivery: United Kingdom
Lot 6 Lot 6 - Lanadelumab
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Offer reference number: CM/PHS/19/5583. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreemen...
Delivery: United Kingdom
Lot 7 Lot 7 - Berotralstat
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Offer reference number: CM/PHS/19/5583. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreemen...
Delivery: United Kingdom
Lot 2 Lot 2 - C1 Esterase – Plasma derived IV (acute treatment)
Value not provided
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Offer reference number: CM/PHS/19/5583. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreemen...
Delivery: United Kingdom
Lot 4 Lot 4 - C1 Esterase – Plasma derived Subcut (prophylaxis treatment)
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Offer reference number: CM/PHS/19/5583. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreemen...
Delivery: United Kingdom
Lot 5 Lot 5 - Icatibant
£1
NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Offer reference number: CM/PHS/19/5583. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 30 months. Total maximum framework agreemen...
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.